FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-4.39%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$843M
AUM Growth
+$843M
(-45%)
Cap. Flow
-$626M
Cap. Flow
% of AUM
-74.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Moderna
MRNA
|
$598M |
| 2 |
Denali Therapeutics
DNLI
|
$28M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Moderna
MRNA
$9.37B
| $550M | 65.22% | 4,632,149 -5,033,889 | -52% | -$598M |
|
2
Sana Biotechnology
SANA
$777M
| $137M | 16.19% | 25,001,856 | – | – |
|
3
Foghorn Therapeutics
FHTX
$286M
| $72.9M | 8.64% | 12,674,120 | – | – |
|
|
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $60.5M | 7.17% | 29,225,579 | – | – |
|
5
Seres Therapeutics
MCRB
$166M
| $16.7M | 1.98% | 23,117,045 | – | – |
|
|
SYRS
6
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $6.68M | 0.79% | 1,293,849 | – | – |
|
|
7
Denali Therapeutics
DNLI
$2.23B
| – | – | -1,364,516 | Closed | -$28M |
|